Piper Sandler Maintains Overweight on Codexis, Lowers Price Target to $8
Piper Sandler analyst Kashy Harrison maintains Codexis (NASDAQ:CDXS) with a Overweight and lowers the price target from $9 to $8.
Read original at benzingaStocks · News reference
8-K filing — CODEXIS, INC. (CDXS)
Filed: 2026-07-27 AccNo: 0001193125-26-318042 Size: 465 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Jul 27, 2026, 8:02 PM
- Checked
- Jul 27, 2026, 8:02 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Codexis Affirms FY2026 Sales Guidance of $72.000M-$76.000M vs $74.099M Est
Codexis (NASDAQ:CDXS) affirms FY2026 sales outlook from $72.000 million-$76.000 million to $72.000 million-$76.000 million vs $74.099 million estimate.
Read original at benzingaCodexis Q2 EPS $(0.13) Beats $(0.14) Estimate, Sales $14.915M Beat $14.348M Estimate
Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 18.75 percent increase over losses of $(0.16) per share from the same
Read original at benzingaCodexis 13G Filing Shows Telemark Fund LP Reported A 7.3% Stake In The Co As Of July 24, 2026
Read original at benzinga